TGF-beta 1

TGF-beta 1

TGF-beta 1 Overview

Molecule Name
Transforming growth factor beta 1
Synonyms
CEDLAP,TGF-beta 1,TGFB1,DPD1,TGF-beta-1,TGFB
Drug Development Progress
Drugs in Clinical Trials22
Approved Drugs1
Highest Development StageApproved
Target Synonym
Latency-Associated Peptide,IBDIMDE,Transforming Growth Factor beta1,Prepro-Transforming Growth Factor Beta-1,TGF-Beta-1,Transforming Growth Factor, Beta 1,CED,TGFB,DPD1,TGFB1,Transforming Growth Factor Beta-1 Proprotein,Camurati-Engelmann Disease,LAP,TGFbeta,Transforming Growth Factor Beta 1,Diaphyseal Dysplasia 1, Progressive,TGF-Beta1
Background
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGFB family members. This encoded protein regulates cell proliferation, differentiation and growth, and can modulate expression and activation of other growth factors including interferon gamma and tumor necrosis factor alpha. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease. [provided by RefSeq, Aug 2016]

TGF-beta 1 Product List

Species
  • Human(5)
  • Mouse / Rat(3)
Tag
  • Tag Free(6)
  • Avi Tag(2)
Host
  • HEK293(6)
  • CHO(2)
Conjugate
  • Unconjugated(6)
  • Biotin-labeled(2)
Grade
  • RUO(6)
  • GMP(1)
  • PG (pre-GMP)(1)
Low Endotoxin
  • No(8)
MoleculeCat. No.Product NameSpeciesHostStructurePurityActivitySize&Price
TGF-beta 1
Human TGF-Beta 1 / TGFB1 Protein, Tag Free
Human
HEK293
SDS-PAGE
ELISASPRCELL BASE

$305.00

10ug
TGF-beta 1
Biotinylated Human TGF-Beta 1 / TGFB1 Protein, Avitag™
Human
HEK293
SDS-PAGE
ELISASPRBLI

$670.00

20ug
TGF-beta 1
Human TGF-Beta 1 / TGFB1 Protein, premium grade
Human
HEK293
SDS-PAGE
ELISACELL BASE

$350.00

20ug
TGF-beta 1
GMP Human TGF-Beta 1 / TGFB1 Protein
Human
HEK293
SDS-PAGE
CELL BASE

$650.00

25ug
TGF-beta 1
Human TGF-Beta 1 / TGFB1 Protein, Research Grade
Human
HEK293
SDS-PAGE
ELISACELL BASE

$200.00

20ug
TGF-beta 1
Mouse / Rat TGF-Beta 1 / TGFB1 Protein, Tag Free
Mouse / Rat
HEK293
SDS-PAGE
ELISA

$360.00

50ug
TGF-beta 1
Mouse / Rat TGF-Beta 1 / TGFB1 Protein, Tag Free (HPLC verified)
Mouse / Rat
CHO
HPLCSDS-PAGE
ELISA

$420.00

100ug
TGF-beta 1
Avitag
TG1-M8313
Biotinylated Mouse / Rat TGF-Beta 1 / TGFB1 Protein, Avitag™
Mouse / Rat
CHO
SDS-PAGE
ELISA

$670.00

20ug
You Have Viewed 1-8 Of 8 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
VactosertibTEW-7197; EW-7197; NOV-1301Phase 3 ClinicalMedpacto Inc
Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colorectal Neoplasms; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Osteosarcoma; Solid tumours; Stomach Neoplasms; Urologic Neoplasms
Details
Bintrafusp alfaM-7824; GSK-4045154; MSB-0011359CPhase 3 ClinicalMerck Serono
Anus Neoplasms; Biliary Tract Neoplasms; Brain metastases; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Small Cell; Carcinoma, Transitional Cell; Cholangiocarcinoma; Colonic Neoplasms; Colorectal Neoplasms; Esthesioneuroblastoma, Olfactory; Gallbladder Neoplasms; Ganglioglioma; Head and Neck Neoplasms; Hematologic Neoplasms; Intestinal Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Metastatic breast cancer; Microsatellite Instability; Nasopharyngeal Carcinoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Germ Cell and Embryonal; Nose Neoplasms; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Papillomavirus Infections; Penile Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Respiratory papillomatosis; Sarcoma; Sarcoma, Kaposi; Skin Melanoma; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thymic epithelial tumor; Thymoma; Thymus Neoplasms; Triple Negative Breast Neop
Details
NisevokitugNIS-793Phase 3 ClinicalXoma Corp
Adenocarcinoma; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Kidney Neoplasms; Lung Neoplasms; Myelodysplastic Syndromes; Pancreatic Neoplasms; Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential
Details
Yinfenidone HydrochlorideHEC-585; HEC-00000585Phase 3 ClinicalHec Pharm Co Ltd
Idiopathic Pulmonary Fibrosis; Lung Diseases, Interstitial; Pulmonary Fibrosis
Details
SB-01 (Ensol BioSciences)Peniel-2000; SB-01; Peniel 2K; YH14618; YH-14618; P2KPhase 3 ClinicalEnsol Biosciences Inc
Intervertebral Disc Degeneration; Intervertebral disc disease; Low Back Pain
Details
LivmoniplimabMGH-8; AGRX-115; ABBV-151; MHG-8; ARGX-115Phase 3 ClinicalArgenx Se
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Solid tumours
Details
Dalutrafusp alfaGS-1423; AGEN-1423Phase 2 ClinicalAgenus Inc
Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Liver Neoplasms; Pancreatic Neoplasms; Solid tumours
Details
ZSP-1603ZSP-1603Phase 2 ClinicalGuangdong Zhongsheng Pharmaceutical Co Ltd, Wuxi Apptec Co Ltd
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Idiopathic Pulmonary Fibrosis; Liver Neoplasms; Ovarian Neoplasms; Solid tumours; Thyroid Neoplasms
Details
NicousamideXLF-III-43Phase 2 ClinicalInstitue Of Materia Medica Chinese Academy Of Medical Science
Diabetic Nephropathies; Hypertensive nephropathy
Details
Meflonidone hydrochloridePhase 2 ClinicalCentral South University, Guangzhou Nanxin Pharma Co Ltd
Diabetes Mellitus, Type 2; Diabetic Nephropathies
Details
FluorofenidoneAKF-PDPhase 2 ClinicalCentral South University, Dierepharma HK Ltd, Hainan Haiyao Co Ltd
Hepatitis B, Chronic; Liver Cirrhosis
Details
CotsiranibSTP-705LU; STP-705LV; STP-705; STP-705LPhase 2 ClinicalSirnaomics, Sirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Carcinoma, Basal Cell; Carcinoma, Basosquamous; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cicatrix, Hypertrophic; Keloid; Liver Neoplasms; Obesity, Abdominal
Details
YL-13027YL-13027Phase 2 ClinicalYL-Pharma
Pancreatic Neoplasms; Solid tumours
Details
MR-001MR001; MR-001Phase 2 ClinicalShenzhen Maijiarui Biotechnology Co Ltd
Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
Details
LinavonkibartSRK-181; SRT-BETA-1-AB3Phase 1 ClinicalScholar Rock Inc
Neoplasms
Details
Charis-1000Charis-1000; C 1K; C1KPhase 1 ClinicalEnsol Biosciences Inc
Breast Neoplasms
Details
HLX-6018HLX-6018; HLX6018Phase 1 Clinical
Idiopathic Pulmonary Fibrosis
Details
RO7496353RO7496353; RO-7496353; SOF 10; RG6440; RG-6440Phase 1 ClinicalGenentech Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Solid tumours; Stomach Neoplasms
Details
JYB-1907JYB-1907Phase 1 ClinicalJiangxi Jemincare Group Co Ltd
Solid tumours
Details
STP-707STP-707; STP707Phase 1 ClinicalSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Cholangitis, Sclerosing; Liver Cirrhosis; Liver Neoplasms; Pancreatic Neoplasms; Pulmonary Fibrosis; Solid tumours
Details
PXS-64PXS-64Phase 1 ClinicalSyntara Ltd
Multiple Sclerosis
Details
BMS-986416BMS-986416; AVID-200 DP; AVID-200Phase 1 ClinicalFormation Biologics Corp
Polycythemia Vera; Primary Myelofibrosis; Scleroderma, Diffuse; Solid tumours; Thrombocythemia, Essential
Details

Marketed Drug Information

English NameResearch CodeHighest Development StageCompanyFirst Brand NameFirst Approved CountryFirst IndicationFirst Approved CompanyFirst Approved DateIndicationClinical Trial
Tonogenchoncel-LTG-CApprovedTissuegeneInvossa-K, InvossaSouth KoreaOsteoarthritisnull2017-07-01
Intervertebral Disc Degeneration; Osteoarthritis; Osteoarthritis, Knee
Details
Customer Reviews
  • 1***22019-10-12
    The TGFb1 protein was used as the negative comparing group in T-cell suppression experiments. The protein has a good bioactivity at suppressing T-cells by significantly inhibiting the proliferation of T-cells stimulated by anti-CD3. The repeatability and stability of the experiment was pretty good.